Search

Researchers from Memorial Sloan Kettering Cancer Center (MSK), in collaboration with an international research team and the ECOG-ACRIN Cancer Research Group, have found that abbreviated breast magnetic resonance imaging (MRI) detected more cancers than digital breast tomosynthesis (3-D mammography) in average-risk women with dense breast tissue.

… Tuesday, February 25, 2020 Researchers from Memorial Sloan Kettering Cancer Center (MSK), in collaboration with an international research team and the ECOG-ACRIN Cancer Research Group , have found that abbreviated breast magnetic resonance imaging (MRI) detected more cancers than digital breast tomosynthesis

… Tuesday, June 25, 2024 The internet is full of “miracle cures” for cancer and alleged surefire ways to prevent it, and well-meaning people may urge cancer patients to just try them out in hopes of eliminating their disease. Some patients, worried that conventional treatments won’t work or pose significant

Learn how multiple myeloma prognosis has improved significantly with the emergence of new drug treatments.

… Tuesday, January 27, 2026 Note: This story was originally published in 2022 and has been updated. Saad Usmani, MD , a hematologic oncologist specializing in multiple myeloma , is Chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center (MSK). Dr. Usmani has more than 15 years of experience

Gerstner Sloan Kettering held its inaugural retreat, on April 30 and May 1, to foster scientific and personal exchanges between students and faculty.

… Saturday, May 15, 2010 Gerstner Sloan Kettering held its inaugural retreat, on April 30 and May 1, to foster scientific and personal exchanges between students and faculty. The retreat brought together 32 students and 28 faculty members, as well as school leadership and keynote speakers for two days

Researchers found that Black race was the strongest predictor of lymphedema development with a 3.5-fold increased incidence of lymphedema in Black women compared to White women.

… Tuesday, December 7, 2021 New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2021 San Antonio Breast Cancer Symposium (SABCS) press program highlights the important impact that race and ethnicity have on the incidence and severity of breast cancer–related lymphedema

The tool will aid basic and translational researchers interested in understanding why immune cells stop working.

… Friday, April 23, 2021 Our immune system is great at protecting us from infections and cancer. Except when it doesn’t. For reasons that are not entirely clear, the T cells that normally mount an effective response against infections and cancer sometimes find themselves unable to vanquish these foes and

Researchers at MSK published updated data today in the New England Journal of Medicine from the ongoing, single-arm Phase II VISION study evaluating tepotinib as a single agent in patients with advanced non-small cell lung cancer (NSCLC) with MET exon 14 (METex14) skipping alterations.

… Friday, May 29, 2020 Researchers at Memorial Sloan Kettering Cancer Center (MSK) published updated data today in the New England Journal of Medicine from the ongoing, single-arm phase II VISION study evaluating tepotinib as a single agent in patients with advanced non-small cell lung cancer (NSCLC) with

Longtime donors Fiona and Stanley Druckenmiller have contributed a transformative gift of $100 million to MSK through their foundation. The gift will be used to launch the Fiona and Stanley Druckenmiller Presidential Innovation Fund.

… Tuesday, January 11, 2022 Memorial Sloan Kettering Cancer Center (MSK) today announced the launch of the Fiona and Stanley Druckenmiller Presidential Innovation Fund. The new initiative, made possible by a transformative $100 million gift from the Fiona and Stanley Druckenmiller Foundation, is expected

Deb Schrag, MD, MPH, gastrointestinal oncologist and Chair of the Department of Medicine, presented results from a randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total surgical excision for the treatment of patients with locally advanced rectal cancer.

… Sunday, June 4, 2023 New data led by researchers at Memorial Sloan Kettering Cancer Center (MSK) and Dana-Farber Brigham Cancer Center featured in the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting press program and simultaneously published in  The New England Journal of Medicine (NEJM

… Thursday, April 3, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Almudena Chaves Perez, Adriana Mujal, Hina Shah, and Lydia Paraskevi Tsamouri Awarded the 2025 Kravis WiSE Fellowships Almudena Chaves Perez, Adriana Mujal, Hina Shah, and Lydia